- Home
- EPSM vs AVTX Comparison
EPSM vs AVTX Comparison
Compare EPSM & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSM
- AVTX
- Stock Information
- Founded
- EPSM 2010
- AVTX 2011
- Country
- EPSM China
- AVTX United States
- Employees
- EPSM N/A
- AVTX N/A
- Industry
- EPSM
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- EPSM
- AVTX Health Care
- Exchange
- EPSM Nasdaq
- AVTX Nasdaq
- Market Cap
- EPSM 71.7M
- AVTX 57.4M
- IPO Year
- EPSM 2025
- AVTX 2015
- Fundamental
- Price
- EPSM $13.56
- AVTX $4.35
- Analyst Decision
- EPSM
- AVTX Strong Buy
- Analyst Count
- EPSM 0
- AVTX 6
- Target Price
- EPSM N/A
- AVTX $34.20
- AVG Volume (30 Days)
- EPSM 786.7K
- AVTX 67.7K
- Earning Date
- EPSM 01-01-0001
- AVTX 05-20-2025
- Dividend Yield
- EPSM N/A
- AVTX N/A
- EPS Growth
- EPSM N/A
- AVTX N/A
- EPS
- EPSM 0.02
- AVTX N/A
- Revenue
- EPSM $12,518,070.00
- AVTX $441,000.00
- Revenue This Year
- EPSM N/A
- AVTX N/A
- Revenue Next Year
- EPSM N/A
- AVTX N/A
- P/E Ratio
- EPSM $684.47
- AVTX N/A
- Revenue Growth
- EPSM N/A
- AVTX N/A
- 52 Week Low
- EPSM $4.23
- AVTX $4.15
- 52 Week High
- EPSM $17.63
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- EPSM N/A
- AVTX 32.20
- Support Level
- EPSM N/A
- AVTX $4.80
- Resistance Level
- EPSM N/A
- AVTX $5.26
- Average True Range (ATR)
- EPSM 0.00
- AVTX 0.47
- MACD
- EPSM 0.00
- AVTX 0.05
- Stochastic Oscillator
- EPSM 0.00
- AVTX 15.15
About EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale seller of beverages in Macau. The company import and sell a range of beverages, alcoholic beverages and a small quantity of tea and fruit juice. The alcoholic beverages sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol. It products include Chinese liquors, French cognac, and Scottish whiskey.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).